Press release
The Role Of Kidney Biopsy In Addressing The Surge In Renal Cancer Cases: A Key Driver Powering Kidney Biopsy Market Growth In 2025
Kidney Biopsy Market
What Is the Current Kidney Biopsy Market Size and Its Estimated Growth Rate?
The kidney biopsy market will grow from $2.14 billion in 2024 to $2.27 billion in 2025, at a CAGR of 5.8%. The growth is attributed to increased chronic kidney diseases, awareness of early diagnosis, an aging population, and government initiatives for kidney disease management.
The kidney biopsy market is expected to see solid growth, reaching $2.8 billion by 2029 at a CAGR of 5.4%. This growth is driven by the rising prevalence of kidney diseases, increased healthcare expenditure, growing awareness of early diagnosis, an aging population, and rising demand for minimally invasive procedures. Major trends include advancements in biopsy techniques, the adoption of minimally invasive procedures, innovations in imaging technologies, AI integration for precision, and technological developments in biopsy devices.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458
How Are Emerging Segments Shaping the Kidney Biopsy Market Landscape?
The kidney biopsy market covered in this report is segmented -
1) By Type: Percutaneous Biopsy, Surgical Biopsy
2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria
3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users
Subsegments:
1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy
2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp
Which Growth Factors Are Influencing Kidney Biopsy Market Expansion?
The rising incidence of renal cancer is expected to fuel growth in the kidney biopsy market. Renal cancer occurs due to the uncontrolled growth of kidney cells and is on the rise because of lifestyle changes, environmental toxins, and improved detection techniques. Kidney biopsies are essential for diagnosing and managing renal cancer, including cancer grade, treatment planning, and monitoring treatment response. According to Cancer Research UK, new kidney cancer cases are expected to rise from 16,300 in 2023 to about 21,900 by 2025. This increase in renal cancer incidence is driving the growth of the kidney biopsy market.
Who Are the Dominant Players Across Different Kidney Biopsy Market Segments?
Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, dic*kinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex
What Kidney Biopsy Market Trends Are Gaining Traction Across Different Segments?
Prominent businesses in the kidney biopsy market are making strides in innovation through the incorporation of artificial intelligence (AI) to heighten diagnostic precision, streamline protocols, and boost patient outcomes. AI plays a crucial role in strengthening kidney biopsy procedures through improved image interpretation, diagnostic assistance, help in devising treatment plans, predictive analysis provision, and fostering advancements in kidney disease research. For instance, the NephroPath platform was introduced in March 2024 by Aiosyn, a software company established in the Netherlands. By using computational pathology algorithms, the NephroPath platform can break down histological biomarkers in kidney biopsies-such activities include tissue type identification, interstitial fibrosis measurement, and precise glomeruli accounting and assessment. This AI-guided analysis maintains consistent, thorough, and repeatable scoring of renal pathology biomarkers, effectively addressing the limitations of traditional scoring methods and observer bias.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report
Which Geographic Regions Are Expected to Dominate the Kidney Biopsy Market in the Coming Years?
North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Kidney Biopsy Market?
2. What is the CAGR expected in the Kidney Biopsy Market?
3. What Are the Key Innovations Transforming the Kidney Biopsy Industry?
4. Which Region Is Leading the Kidney Biopsy Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Role Of Kidney Biopsy In Addressing The Surge In Renal Cancer Cases: A Key Driver Powering Kidney Biopsy Market Growth In 2025 here
News-ID: 4039710 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Biopsy
Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430
This latest report researches the industry structure, sales, revenue,…
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from…
